Headlines

On July 21, 2011, The New England Journal of Medicine published a study that should help some veterans prove their respiratory illnesses are service-related.

Following extensive negotiation and a week-long trial delay issued by Judge Carl Barbier in the BP multidistrict litigation (MDL), the Plaintiffs' Steering Committee (PSC) for the MDL has reached a settlement in principle with BP that, if approved by the court, would compensate hundreds of thousands of…

On Monday, April 28, 2014, in one of the few cases interpreting the Alien Tort Statute (ATS) post the Supreme Court’s ruling in Kiobel v. Royal Dutch Shell Petroleum, U.S. District Judge Jose Linares denied motions to dismiss filed by Defendants concerning the extraterritorial reach of the ATS in Krishanti, et al., v…

On July 13, 2011, the FDA issued an urgent public notice advising patients and their healthcare providers to consider alternatives to transvaginal mesh (TVM).

On May 2, 2014, a proposed $57 million settlement for the benefit of investors in Hewlett-Packard Company (HP) received preliminary court approval.

The 9/11 Families United to Bankrupt Terrorism issued a statement today in support of former Senators Bob Graham (FL) and Bob Kerrey (NE), who entered declarations in federal court supporting further investigation into possible connections between Saudi Arabia, the Saudi High Commission and the 9/11 terrorist attacks.

On July 27, 2011, Judge Alvin K. Hellerstein said that he may allow the family of Mark Bavis to seek damages against United Airlines et al—not only for his death but also for the "21 minutes of terror" he endured prior to the plane's crash.

One week after three U.S. Airways passenger planes nearly collided on July 31, 2012, over Washington's Reagan National Airport, the Federal Aviation Administration (FAA) announced a ban on traffic-switching.

The Institute of Medicine (IOM), an advisory group for the Food and Drug Administration (FDA), issued a report proposing that the 510(k) accelerated approval program for medical devices be replaced.

Motley Rice is proud to again support the Mesothelioma Applied Research Foundation (MARF) as a "2012 Legal Partner for a Cure for Mesothelioma." A national non-profit organization dedicated to finding a cure for mesothelioma and eradicating the devastating disease, the Foundation takes the following actions…